CEI NUTRI INC – Trademark Portfolio

Entity Type: 03

CEI NUTRI INC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include DYNAX. The owner is based in Weston, FL.

2625 Weston Road

Weston, FL 33331

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

CEI NUTRI INC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

43
Hotels & Restaurants (1 filing)

Services for providing food and drink; temporary accommodation

Frequently Asked Questions

How many trademarks does CEI NUTRI INC have?

CEI NUTRI INC has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned.

What trademark classes does CEI NUTRI INC file in?

CEI NUTRI INC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 43 (Hotels & Restaurants). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are CEI NUTRI INC's most well-known trademarks?

CEI NUTRI INC's registered trademark portfolio includes well-known marks such as DYNAX. These are among 1 currently registered trademark in the portfolio.

What is CEI NUTRI INC's trademark registration success rate?

CEI NUTRI INC has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.